Literature DB >> 31397199

Global incidence of bronchopulmonary dysplasia among extremely preterm infants: a systematic literature review.

Csaba Siffel1,2, Kristin D Kistler3, Juliana F M Lewis3, Sujata P Sarda1.   

Abstract

BACKGROUND: Infants born extremely preterm (<28 weeks gestational age (GA)) face a high risk of neonatal mortality. Bronchopulmonary dysplasia (BPD) is the most common morbidity of prematurity.
OBJECTIVE: To evaluate the global incidence of BPD among infants born extremely preterm.
DESIGN: A systematic review of the literature was conducted in Embase and MEDLINE (via PubMed) using a prespecified search strategy for BPD and prematurity. Observational studies published in English between 16 May 2006 and 16 October 2017 reporting on the occurrence of BPD in infants born <28 weeks GA were included.
RESULTS: Literature searches yielded 103 eligible studies encompassing 37 publications from Europe, 38 publications from North America, two publications from Europe and North America, 19 publications from Asia, one publication from Asia and North America, six publications from Oceania, and zero publications from Africa or South America. The reported global incidence range of BPD was 10-89% (10-73% in Europe, 18-89% in North America, 18-82% in Asia, and 30-62% in Oceania). When only population-based observational studies that defined BPD as requiring supplemental oxygen at 36 weeks postmenstrual age were included, the global incidence range of BPD was 17-75%. The wide range of incidences reflected interstudy differences in GA (which was inversely related to BPD incidence), birthweight, and survival rates across populations and institutions.
CONCLUSIONS: BPD is a common health morbidity occurring with extremely preterm birth. Further study of factors that impact incidence, aside from low GA, may help to elucidate modifiable risks.

Entities:  

Keywords:  Bronchopulmonary dysplasia; incidence; prematurity; preterm infants; systematic literature review

Mesh:

Year:  2019        PMID: 31397199     DOI: 10.1080/14767058.2019.1646240

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  24 in total

Review 1.  The current state of retinopathy of prematurity in India, Kenya, Mexico, Nigeria, Philippines, Romania, Thailand, and Venezuela.

Authors:  Theodore Bowe; Lily Nyamai; Dupe Ademola-Popoola; Atchara Amphornphruet; Rachelle Anzures; Linda A Cernichiaro-Espinosa; Roseline Duke; Fahir Duran; Maria Ana Martinez-Castellanos; Prabhujot Kaur Multani; Cristina E Nitulescu; Tapas Ranjan Padhi; Boontip Tipsuriyaporn; R V Paul Chan; J Peter Campbell; Yoshihiro Yonekawa
Journal:  Digit J Ophthalmol       Date:  2019-10-12

2.  Effect of Maternal Docosahexaenoic Acid Supplementation on Bronchopulmonary Dysplasia-Free Survival in Breastfed Preterm Infants: A Randomized Clinical Trial.

Authors:  Isabelle Marc; Bruno Piedboeuf; Thierry Lacaze-Masmonteil; William Fraser; Benoît Mâsse; Ibrahim Mohamed; Mosarrat Qureshi; Jehier Afifi; Brigitte Lemyre; Georges Caouette; Julie Bartholomew; Anne Monique Nuyt; Pierre Julien; Anne Synnes; Michel Lucas; Thérèse Perreault; Lannae Strueby; Zenon Cieslak; Kamran Yusuf; Gustavo Pelligra; Edith Massé; Bodil Larsen; Cecilia de Cabo; Chelsea Ruth; Faiza Khurshid; Pascal M Lavoie
Journal:  JAMA       Date:  2020-07-14       Impact factor: 56.272

3.  Urine Proteomics for Noninvasive Monitoring of Biomarkers in Bronchopulmonary Dysplasia.

Authors:  Saima Ahmed; Oludare A Odumade; Patrick van Zalm; Kinga K Smolen; Kimino Fujimura; Jan Muntel; Melissa S Rotunno; Abigail B Winston; Judith A Steen; Richard B Parad; Linda J Van Marter; Stella Kourembanas; Hanno Steen
Journal:  Neonatology       Date:  2022-01-24       Impact factor: 4.035

4.  Bronchopulmonary dysplasia patients have preserved CT-measured central airway luminal area.

Authors:  Winston L Guo; Ilhan M Eli; Juan G Ripoll; Sarah E Baker; John R A Shepherd; Chad C Wiggins; Brian T Welch; Michael J Joyner; Paolo B Dominelli
Journal:  Respir Med       Date:  2020-06-25       Impact factor: 3.415

5.  Characteristics of infants or children presenting to outpatient bronchopulmonary dysplasia clinics in the United States.

Authors:  Joseph M Collaco; Amit Agarwal; Eric D Austin; Lystra P Hayden; Khanh Lai; Jonathan Levin; Winston M Manimtim; Paul E Moore; Catherine A Sheils; Michael C Tracy; Stamatia Alexiou; Christopher D Baker; A Ioana Cristea; Julie L Fierro; Lawrence M Rhein; Natalie Villafranco; Leif D Nelin; Sharon A McGrath-Morrow
Journal:  Pediatr Pulmonol       Date:  2021-03-13

Review 6.  Influences of environmental exposures on preterm lung disease.

Authors:  Joseph M Collaco; Brianna C Aoyama; Jessica L Rice; Sharon A McGrath-Morrow
Journal:  Expert Rev Respir Med       Date:  2021-06-17       Impact factor: 3.772

7.  New BPD-prevalence and risk factors for bronchopulmonary dysplasia/mortality in extremely low gestational age infants ≤28 weeks.

Authors:  Odattil Geetha; Victor Samuel Rajadurai; Amudha Jayanthi Anand; Rowena Dela Puerta; Bin Huey Quek; Poh Choo Khoo; Mei Chien Chua; Pratibha Agarwal
Journal:  J Perinatol       Date:  2021-05-24       Impact factor: 2.521

8.  Risk Factors and Outcomes of Pulmonary Hypertension in Infants With Bronchopulmonary Dysplasia: A Meta-Analysis.

Authors:  Ying Chen; Di Zhang; Ying Li; Aixia Yan; Xiaoying Wang; Xiaoming Hu; Hangting Shi; Yue Du; Wenhui Zhang
Journal:  Front Pediatr       Date:  2021-06-25       Impact factor: 3.418

9.  The Specific Connexin 43-Inhibiting Peptide Gap26 Improved Alveolar Development of Neonatal Rats With Hyperoxia Exposure.

Authors:  Cai Qing; Zhao Xinyi; Yu Xuefei; Xue Xindong; Fu Jianhua
Journal:  Front Pharmacol       Date:  2021-07-05       Impact factor: 5.810

10.  Rates of Bronchopulmonary Dysplasia Following Implementation of a Novel Prevention Bundle.

Authors:  Maria Fe B Villosis; Karine Barseghyan; Ma Teresa Ambat; Kambiz K Rezaie; David Braun
Journal:  JAMA Netw Open       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.